Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Peringkat dalam Saham #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Harga Saham
$0.2219522
Terakhir disinkronkan: 2025-09-11
Kapitalisasi Pasar
$1.10B
Perubahan (1 hari)
0.04%
Perubahan (1 tahun)
0.17%
Negara
CN
Perdagangan Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Rasio P/B untuk Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Rasio P/B per August 2026 TTM: 0.38
Menurut laporan keuangan dan harga saham terbaru dari Hubei Biocause Pharmaceutical Co., Ltd., rasio P/B saat ini (TTM) adalah 0.38. Pada akhir 2022, rasio P/B perusahaan adalah 0.73.
Riwayat rasio P/B untuk Hubei Biocause Pharmaceutical Co., Ltd. dari 2000 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
2026 (TTM) 0.38 -43.43%
2023 0.68 -6.16%
2022 0.73 0.55%
2021 0.73 -36.31%
2020 1.14 -30.43%
2019 1.64 12.76%
2018 1.45 -21.73%
2017 1.85 -17.26%
2016 2.24 -73.63%
2015 8.50 95.40%
2014 4.35 71.99%
2013 2.53 2.54%
2012 2.47 -12.18%
2011 2.81 -35.80%
2010 4.37 31.02%
2009 3.34 138.44%
2008 1.40 -82.25%
2007 7.89 243.90%
2006 2.29 173.77%
2005 0.84 -59.16%
2004 2.05 -13.52%
2003 2.37 -64.68%
2002 6.71 59.91%
2001 4.20 -11.67%
2000 4.75 0.00%
Rasio P/B untuk perusahaan sejenis atau pesaing